NPAS3

Source: Wikipedia, the free encyclopedia.
NPAS3
Identifiers
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_013780

RefSeq (protein)

NP_001158221
NP_001159365
NP_071406
NP_775182

NP_038808

Location (UCSC)Chr 14: 32.93 – 33.82 MbChr 12: 53.25 – 54.07 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

NPAS3 or Neuronal PAS domain protein 3 is a brain-enriched

basic helix-loop-helix structural motif and PAS domain
, like the other proteins in the superfamily.

Function

NPAS3 is also known as human accelerated region 21. It may, therefore, have played a key role in differentiating humans from apes.[5]

animal models of schizophrenia.[6]

According to the same study, NPAS1 and NPAS3 disruption leads to reduced expression of reelin, which is also consistently found to be reduced in the brains of human patients with schizophrenia and psychotic bipolar disorder. Among the 49 genomic regions that undergone rapid changes in humans compared with their evolutionary ancestors, NPAS3 was found to be located in the region 21.[5]

Clinical significance

Disruption of NPAS3 was found in one family affected by schizophrenia[7] and NPAS3 gene is thought to be associated with psychiatric illness and learning disability.[8][9] In a genetic study of several hundred subjects conducted in 2008, interacting haplotypes at the NPAS3 locus were found to affect the risk of schizophrenia and bipolar disorder.[10]

In a

pharmacogenetical study, polymorphisms in NPAS3 gene were highly associated with response to iloperidone, a proposed atypical antipsychotic.[11]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000151322Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021010Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^
    S2CID 18107797
    .
  6. .
  7. .
  8. .
  9. .
  10. .
  11. ^ Lavedan C, Volpi S, Mack K, et al. Whole-genome association study identifies polymorphisms in the NPAS3 gene associated with super-response to iloperidone treatment in patients with schizophrenia. Program and abstracts of the 57th Annual Meeting of the American Society of Human Genetics; October 23–27, 2007; San Diego, California. Abstract 1035/T

Further reading


This page is based on the copyrighted Wikipedia article: NPAS3. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy